Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Inventory (2018 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Change in Inventory for 7 consecutive years, with $886000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 25.36% year-over-year to $886000.0, compared with a TTM value of $5.3 million through Dec 2025, down 37.89%, and an annual FY2025 reading of $5.3 million, down 37.89% over the prior year.
  • Change in Inventory was $886000.0 for Q4 2025 at Agios Pharmaceuticals, down from $1.2 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $4.3 million in Q2 2023 and bottomed at $867000.0 in Q2 2024.
  • Average Change in Inventory over 4 years is $2.1 million, with a median of $1.7 million recorded in 2023.
  • The sharpest move saw Change in Inventory soared 172.83% in 2023, then plummeted 79.82% in 2024.
  • Year by year, Change in Inventory stood at $3.3 million in 2022, then crashed by 45.66% to $1.8 million in 2023, then plummeted by 34.13% to $1.2 million in 2024, then dropped by 25.36% to $886000.0 in 2025.
  • Business Quant data shows Change in Inventory for AGIO at $886000.0 in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.